Bafna Pharmaceuticals share news and announcements
NSE: BAFNAPHBSE: 532989Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹451.95.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,048 Cr2,105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 134.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 10.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 8.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 4.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day.
- 1,422
Bafna Pharmaceuticals share news and announcements
637 announcements, routine notices left out, newest first. Page 9 of 13.
Jun 2016
17 Jun · Board meeting
Board of Directors of the Company at its meeting held on June 17, 2016, considered and approved the proposal for Allotment of Equity ....10 Jun · Board Meeting on June 17, 2016
Meeting of the Board of Directors of the Company will be held on June 17, 2016 to consider the proposal of issue of Equity Shares to Promoter ....
May 2016
11 May · Shareholding for the Period Ended March 31, 2016
Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....
Apr 2016
7 Apr · Updates
Company has been registered with Department of Scientific & Industrial Research for the purpose of availing customs /central excise duty ....7 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Mar 2016
3 Mar · Management
Mr. M. R. Ramachandran, Chief Financial Officer has submitted his resignation and relieved from the services of the Company effective from ....
Feb 2016
12 Feb · Authorised KMPs to determine materiality of events/information
11 Feb · Limited Review Report for December 31, 2015
7 Feb · Shareholding for the Period Ended December 31, 2015
Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click ....
Jan 2016
13 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Nov 2015
20 Nov · Limited Review Report for Sept 30, 2015
Oct 2015
16 Oct · Shareholding Pattern for September 30, 2015
Sep 2015
Aug 2015
Jul 2015
14 Jul · Shareholding Pattern For June 30, 2015
Jun 2015
4 Jun · Code of Conduct of Fair Disclosure
May 2015
30 May · Board meeting
30 May · Management
30 May · Code of Conduct under SEBI(PIT) Reg., 2015
29 May · Board meeting
Board of Directors of the Company at its meeting held on May 29, 2015, inter alia : 1. Not recommended Dividend for the Financial ....
Apr 2015
14 Apr · Shareholding Pattern For March 31, 2015